z-logo
open-access-imgOpen Access
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
Author(s) -
Kenneth E. Schmader,
Michael N. Oxman,
Myron J. Levin,
Gary R. Johnson,
J. H. Zhang,
Robert F. Betts,
V. A. Morrison,
Lawrence Gelb,
J C Guatelli,
Ruth Harbecke,
C. T. Pachucki,
S. Keay,
Barbara E. Menzies,
Marie R. Griffin,
Carol A. Kauffman,
Adriana Marques,
John Toney,
Paul M. Keller,
X. Li,
I. S. F. Chan,
Paula W. Annunziato
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis638
Subject(s) - persistence (discontinuity) , shingles , medicine , term (time) , virology , virus , geotechnical engineering , engineering , physics , quantum mechanics
The Shingles Prevention Study (SPS; Department of Veterans Affairs Cooperative Study 403) demonstrated that zoster vaccine was efficacious through 4 years after vaccination. The Short-Term Persistence Substudy (STPS) was initiated after the SPS to further assess the persistence of vaccine efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom